Summary
Updated Aug 30, 2026
Keith G. Myers is Director of Sanara MedTech Inc. (SMTI). 2 SEC Form 4 filings on record going back to 2024, most recently on 6 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Keith G. Myers has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Keith G. Myers's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Paul R. Vigano - $371.84M of AVAH open-market activity in the last 12 months
- Robert M. Williams Jr. - $371.84M of AVAH open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Keith G. Myers?
Keith G. Myers is a corporate insider, tracked as Director of Sanara MedTech Inc. (SMTI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Keith G. Myers submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Keith G. Myers's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Keith G. Myers and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
